Table 5.
ChrIRD | CVD | CHD | Stroke | HF | |
---|---|---|---|---|---|
Quartile 1 (3.7 to 24.3 μmol/L) | 15.7 (13.9 to 17.8) | 9.3 (7.9 to 11) | 5.3 (4.2 to 6.6) | 1.6 (1.1 to 2.4) | 2.2 (1.6 to 3) |
Quartile 2 (24.4 to 27.6 μmol/L) | 14.9 (13.3 to 16.8) | 9.3 (8.0 to 10.8) | 5.4 (4.4 to 6.6) | 1.9 (1.4 to 2.6) | 2.1 (1.6 to 2.9) |
Quartile 3 (27.7 to 31.2 μmol/L) | 11.9 (10.5 to 13.5) | 8.6 (7.4 to 10.0) | 4.9 (4.0 to 6.0) | 2.0 (1.5 to 2.8) | 1.8 (1.3 to 2.5) |
Quartile 4 (31.3 to 56.7 μmol/L) | 11.2 (9.7 to 13.0) | 7.9 (6.6 to 9.4) | 4.1 (3.2 to 5.3) | 1.4 (1.0 to 2.1) | 2.3 (1.6 to 3.2) |
Incidence density per 100 persons followed for 10.1 years (95% CI), by quartiles of medium- plus small- HDL particle concentration in the risk factor and LDL family model. HDL indicates high-density lipoprotein; ChrIRD, noncancer chronic inflammation–related hospitalization and death; CVD, cardiovascular disease; CHD, coronary heart disease; HF, heart failure; LDL, low-density lipoprotein.